SMITHA GUBBI: Open Payments
NPI 1275620650 · BRIDGEWATER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,629 in 95 payments from 21 companies in 2025. Trend: 2023 $1,136 · 2024 $1,758 · 2025 $1,629
Food & beverage: $1,629
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $219 |
| AstraZeneca Pharmaceuticals LP | 11 | $161 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $142 |
| PFIZER INC. | 7 | $117 |
| Kowa Pharmaceuticals America, Inc. | 6 | $91 |
| Astellas Pharma US Inc | 4 | $86 |
| Exact Sciences Corporation | 3 | $86 |
| Lilly USA, LLC | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
Products named: Kerendia, XIFAXAN, Ozempic, BREZTRI, ZORYVE, Veozah, Cologuard Collection Kit, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
